About FDA

Office of Manufacturing Quality

Office Director: Thomas J. Cosgrove

Office Deputy Director for Science and Regulatory Policy: Rick Friedman

Office Deputy Director for Management and Operations: Kennerly Chapman

Drugs, prescription and over-the-counter (OTC), must be manufactured in accordance with good manufacturing practice requirements. Conformance with these requirements is determined through inspection and compliance evaluations. After approval, routine FDA inspections evaluate the state of control of the process and facility, under the agency’s quality systems inspection program.

Page Last Updated: 03/29/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English